← back to search

Kyle P. Openo

Emory University · US
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Respiratory viral infections research, COVID-19 Clinical Research Studies, Influenza Virus Research Studies, and COVID-19 and healthcare impacts.
h-index
33
citations
7,212
works
92
NIH funding
primary concept
Medicine
email

Recent publications

Hospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022–2024
PEDIATRICS 2025cited by 8position: middledoi
Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
JAMA Internal Medicine 2024cited by 106position: middledoi
Burden of Respiratory Syncytial Virus–Associated Hospitalizations in US Adults, October 2016 to September 2023
JAMA Network Open 2024cited by 64position: middledoi
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2019
Clinical Infectious Diseases 2024cited by 22position: middledoi
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019
Clinical Infectious Diseases 2024cited by 15position: middledoi
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023
MMWR Morbidity and Mortality Weekly Report 2023cited by 76position: middledoi
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study
The Lancet Microbe 2023cited by 50position: middledoi
Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19
PEDIATRICS 2023cited by 29position: middledoi
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
JAMA Internal Medicine 2022cited by 191position: middledoi
Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
MMWR Morbidity and Mortality Weekly Report 2022cited by 172position: middledoi
Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure—United States, 2015–2017
PLoS ONE 2022cited by 69position: middledoi
Comparison of Influenza and Coronavirus Disease 2019–Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021)
Clinical Infectious Diseases 2022cited by 49position: middledoi
Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic
Clinical Infectious Diseases 2022cited by 48position: middledoi
Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021
JAMA Network Open 2021cited by 254position: middledoi
Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020
Annals of Internal Medicine 2021cited by 59position: middledoi
Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015–2017
BMC Infectious Diseases 2021cited by 33position: middledoi
Risk Factors for Coronavirus Disease 2019 (COVID-19)–Associated Hospitalization: COVID-19–Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System
Clinical Infectious Diseases 2020cited by 371position: middledoi
Estimated Burden of Community-Onset Respiratory Syncytial Virus–Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014–15
Journal of the Pediatric Infectious Diseases Society 2019cited by 127position: middledoi
Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011–2015
Clinical Infectious Diseases 2019cited by 74position: middledoi
Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011–2015
Journal of the Pediatric Infectious Diseases Society 2018cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Evan J. Anderson · Emory University6 papers (2018–2022)William Schaffner · Vanderbilt University Medical Center5 papers (2018–2022)Ann Thomas · Oregon Health Authority5 papers (2018–2022)Nancy M. Bennett · University of Rochester4 papers (2018–2022)Angela P. Campbell · Seattle Children's Hospital4 papers (2018–2025)Ruth Lynfield · Minnesota Department of Health4 papers (2018–2022)Maya Monroe · Maryland Department of Health4 papers (2018–2022)Shua J. Chai · Centers for Disease Control and Prevention4 papers (2019–2022)Shikha Garg · Centers for Disease Control and Prevention4 papers (2018–2022)H. Keipp Talbot · Vanderbilt University Medical Center4 papers (2021–2025)Laurie M. Billing · Ohio Department of Health3 papers (2018–2022)Rachel Herlihy · Colorado Department of Public Health and Environment3 papers (2018–2022)Christina B. Felsen · Georgia Christian University3 papers (2021–2022)Alison Muse · New York State Department of Health3 papers (2021–2022)Pam Daily Kirley · Minnesota Department of Health3 papers (2018–2021)Erica Bye · Minnesota Department of Health3 papers (2019–2022)Kimberly Yousey‐Hindes · Yale New Haven Health System3 papers (2018–2022)Gayle Langley · University of Rochester3 papers (2019–2022) · 3 papers (2018–2022)Lindsay Kim · Centers for Disease Control and Prevention3 papers (2019–2022)